Arcellx Inc (ACLX) support and resistance · rev $107.9M
Arcellx Inc (ACLX) is a biotechnology company listed on NASDAQ.
This page maps Arcellx Inc (ACLX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ACLX revenue for 2024-12-31 was $107.9M. Net income was -$107.3M. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. ACLX currently screens at market cap $6.73B.
ACLX currently screens at market cap $6.73B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ACLX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ACLX quote page for the session range and the stock page for the full model.
Not investment advice.